TAp73 is a marker of glutamine addiction in medulloblastoma.

TAp73 is a marker of glutamine addiction in medulloblastoma.
复制标题

DOI:
10.1101/gad.302349.117
复制
发表时间:
2017-09-01
影响因子:
10.5
通讯作者:
Marino S
Marino S
中科院分区:
生物学1区
文献类型:
--
作者:
Niklison-Chirou MV;Erngren I;Engskog M;Haglöf J;Picard D;Remke M;McPolin PHR;Selby M;Williamson D;Clifford SC;Michod D;Hadjiandreou M;Arvidsson T;Pettersson C;Melino G;Marino S

文献摘要

参考文献

被引文献

相似文献

尼克利森-奇鲁等人。确定了一部分非 WNT 髓母细胞瘤,其中 p73 通过调节谷氨酰胺代谢维持细胞生长和增殖。髓母细胞瘤是儿童中最常见的实体原发性脑肿瘤。对这些肿瘤的遗传和表观遗传基础的理解取得了显着进展,为它们最近的分子分类提供了信息。然而,亚组的基因型/表型相关性在很大程度上仍然未知。特别是,代谢表型因其成药性而引起人们极大的兴趣,这可能会导致针对髓母细胞瘤的一个子集开发新颖且更具针对性的疗法。 p73 在一系列细胞代谢过程中发挥着关键作用。我们发现 p73 在一定比例的非 WNT 髓母细胞瘤中过度表达。在这些肿瘤中,p73 通过调节谷氨酰胺代谢来维持细胞生长和增殖。我们在异种移植模型中验证了我们的结果,在该模型中我们观察到限制谷氨酰胺饮食的小鼠的存活时间有所增加。值得注意的是,谷氨酰胺饥饿与顺铂(当前髓母细胞瘤化疗的一个组成部分)具有协同作用。这些发现提出了谷氨酰胺消耗可用作表达 p73 的髓母细胞瘤的辅助治疗的可能性。
Niklison-Chirou et al. identify a proportion of non-WNT medulloblastoma in which p73 sustains cell growth and proliferation via regulation of glutamine metabolism. Medulloblastoma is the most common solid primary brain tumor in children. Remarkable advancements in the understanding of the genetic and epigenetic basis of these tumors have informed their recent molecular classification. However, the genotype/phenotype correlation of the subgroups remains largely uncharacterized. In particular, the metabolic phenotype is of great interest because of its druggability, which could lead to the development of novel and more tailored therapies for a subset of medulloblastoma. p73 plays a critical role in a range of cellular metabolic processes. We show overexpression of p73 in a proportion of non-WNT medulloblastoma. In these tumors, p73 sustains cell growth and proliferation via regulation of glutamine metabolism. We validated our results in a xenograft model in which we observed an increase in survival time in mice on a glutamine restriction diet. Notably, glutamine starvation has a synergistic effect with cisplatin, a component of the current medulloblastoma chemotherapy. These findings raise the possibility that glutamine depletion can be used as an adjuvant treatment for p73-expressing medulloblastoma.
EEF2激酶通过阻止翻译伸长来赋予对营养剥夺的耐药性。
DOI: 10.1016/j.cell.2013.04.055
发表时间: 2013-05-23
期刊: Cell
影响因子: 64.5
作者:
Leprivier G;Remke M;Rotblat B;Dubuc A;Mateo AR;Kool M;Agnihotri S;El-Naggar A;Yu B;Somasekharan SP;Faubert B;Bridon G;Tognon CE;Mathers J;Thomas R;Li A;Barokas A;Kwok B;Bowden M;Smith S;Wu X;Korshunov A;Hielscher T;Northcott PA;Galpin JD;Ahern CA;Wang Y;McCabe MG;Collins VP;Jones RG;Pollak M;Delattre O;Gleave ME;Jan E;Pfister SM;Proud CG;Derry WB;Taylor MD;Sorensen PH
通讯作者: Sorensen PH
DOI: 10.4161/cc.27267
发表时间: 2013-12-15
期刊: CELL CYCLE
影响因子: 4.3
作者:
Jiang, Peng;Du, Wenjing;Yang, Xiaolu
通讯作者: Yang, Xiaolu
DOI: 10.1101/gad.319905
发表时间: 2005-02-01
影响因子: 10.5
作者:
Asher, G;Tsvetkov, P;Shaul, Y
通讯作者: Shaul, Y
DOI: 10.1016/j.ccell.2014.11.002
发表时间: 2015-01-12
期刊: CANCER CELL
影响因子: 50.3
作者:
Hill, Rebecca M.;Kuijper, Sanne;Clifford, Steven C.
通讯作者: Clifford, Steven C.
DOI: 10.1042/bsr20160088
发表时间: 2016-07
期刊: Bioscience reports
影响因子: 4
作者:
Li ZQ;Gu XY;Hu JX;Ping Y;Li H;Yan JY;Li J;Sun R;Yu ZJ;Zhang Y
通讯作者: Zhang Y